Accessing GLP-1 treatment in Millbrae, California has traditionally meant longer waits than mainland patients face. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Millbrae address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Millbrae is already seeing results
Rybelsus in Millbrae, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Millbrae from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Rybelsus® as the FDA-approved Oral tablet product, taken Once daily, approved in 2019. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Millbrae, CA residents starts at $199/month.
Millbrae's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk since 2019. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Semaglutide delivered to your Millbrae address at $199/month. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.